Tests a visible breathing screen during MRI-guided radiotherapy for moving tumors
Tests a visible non-magnetic breathing screen in people treated for moving cancers with MRI-guided radiotherapy.
Key facts
- Who runs it
- Centre Georges Francois Leclerc
- Where
- Dijon, FranceSee the site
- Trial code
- Registry title
- Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 16 Oct 2023
- Planned end
- 27 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- With non-magnetic screen
- Record updated
- 17 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults starting radiotherapy on a Linac MRI machine for a cancerous lesion that moves with breathing. It tests a screen the patient can see during treatment.
- Age
- At least 18 years old (the record's minimum age field says 18 Months, but the inclusion criteria say at least 18 years old).
- Sex
- All sexes can join.
- Disease stage
- A mobile cancerous lesion, most often in the pancreas, liver, kidneys, adrenals, lung, or lymph nodes above or below the diaphragm.
Main reasons for not taking part
- Lesions not detected by the device's tracking system
- Visual disturbances
- Contraindications to Linac MRI treatment (epilepsy, pregnant or breastfeeding women, metallic prosthesis or pacemaker not compatible with MRI)
- Cognitive disorders
- People deprived of liberty or under guardianship (including curatorship)
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patient is at least 18 years old
- Patient starting radiotherapy on Linac MRI for a mobile cancerous lesion most often in the pancreas, liver, kidneys, adrenals, lung, supra or subdiaphragmatic adenopathy
- Patient affiliated to the social security system
Who cannot take part
- Contraindications to treatment with Linac MRI (epileptic patients, pregnant or breastfeeding women, metallic prosthesis or pacemaker not compatible with MRI)
- Patients with cognitive disorders
- Patient with lesions not detected by the device's tracking system
- Patient with visual disturbances
- Persons deprived of liberty or under guardianship (including curatorship)
- Pregnant or nursing woman
- Refusal to participate in the study
Where in France
- Centre Georges François LeclercDijon, FranceContact: Gilles TRUC, DrTaking people
About the trial
What the trial wants to find out
The patients eligible for the study are those treated by radiotherapy on Linac MRI for a mobile cancerous lesion (pancreas, liver, kidneys, adrenals, lung, adenopathy above or below the diaphragm ...).
Read full original descriptionShow less
After signing the consent form, each patient will be randomized to one of two treatment arms:
* Standard arm : Radiotherapy treatment with Linac MRI without non-magnetic shielding * Experimental arm : radiotherapy treatment with Linac MRI with non-magnetic screen The aim is to evaluate the effect of using a non-magnetic screen visible to the patient in the bunker during radiotherapy sessions delivered by Linac MRI on decreasing the ratio between the actual treatment time and the treatment time predicted by the machine.
The 2 groups in the trial
- Without Non-magnetic screenNo study treatment, for comparison
Radiotherapy treatment with Linac MRI without non-magnetic shielding
- With non-magnetic screenTreatment being tested
Radiotherapy treatment with Linac MRI with non-magnetic screen
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
- Plain-language title
- Tests a visible breathing screen during MRI-guided radiotherapy for moving tumorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 17 February 2025